Inside the research
CONMED Corporation
CNMD Research profile · latest available data
Price overview
$45.38
▲ +0.20 (+0.4%)
| 52w hi | $51.86 |
|---|---|
| 52w lo | $32.11 |
| Vol | 282.60K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.37
| Short | +0.31 |
|---|---|
| Medium | +0.48 |
| Long | +0.27 |
computed 2026-09-27
Key fundamentals
CONMED Corporation
Healthcare · Medical Devices
| Market cap | $1.36B |
|---|---|
| Enterprise value | $2.16B |
| Trailing P/E | 24.80x |
| Forward P/E | 9.49x |
| EV / EBITDA | 9.48x |
| P / S (ttm) | 0.99x |
| Profit margin | 4.1% |
| Return on equity | 5.5% |
| Revenue growth | +0.3% |
| Earnings growth | +11.2% |
| Debt / equity | 80.11 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.20 | |
| Sector | +0.08 | |
| Technical | +0.25 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Risk Metrics
| Beta vs SPX | 0.93 |
|---|---|
| Corr SPX | 0.34 |
| Annual vol | 43.9% |
| Annual ret | -15.8% |
| Sharpe | -0.36 |
| Max DD | -58.6% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-29 | Earnings Release, Exhibits | read |
| 2026-06-17 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-06-04 | Material Agreement, Exhibits | read |
| 2026-06-01 | Material Agreement, Material Obligation… | read |
| 2026-05-20 | Officer / Director Change, Bylaws Amendment… | read |
| 2026-04-29 | Earnings Release, Exhibits | read |
| 2026-03-13 | Officer / Director Change | read |
| 2026-01-28 | Earnings Release, Exhibits | read |
| 2026-01-12 | Reg FD Disclosure, Exhibits | read |
| 2026-01-08 | Officer / Director Change, Exhibits | read |
| 2025-12-05 | Reg FD Disclosure, Exhibits | read |
| 2025-11-05 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Bronson David M. | Option exercise | 668 | — | |
| 2026-06-02 | Council LaVerne H | Option exercise | 668 | — | |
| 2026-06-02 | Farkas Charles | Option exercise | 668 | — | |
| 2026-06-02 | Kaye Mark | Option exercise | 668 | — | |
| 2026-06-02 | Schwarzentraub Barbara J | Option exercise | 668 | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 100.0% |
| HHI | 5,368 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $46.39M | 1.42M |
| AQR Capital Management | $9.19M | 280.92K |
| Citadel Advisors | $4.86M | 148.56K |
| Millennium Management | $3.75M | 114.61K |
| Fidelity / FMR LLC | $898.25K | 27.44K |
| Capital Research / Capital World | $1.95K | 2.00K |
| T. Rowe Price Group | $1.47K | 44.89K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.37B | +4.7% | |
| Gross profit | $676.25M | +15.6% | |
| Operating income | $200.33M | +9.4% | |
| Net income | $132.42M | +23.8% | |
| Cash from ops | $125.35M | +12.2% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $45.30 | $46.51 | $45.10 | $45.38 | 282.60K |
| Sep 24 | $45.59 | $45.95 | $44.79 | $45.18 | 263.30K |
| Sep 23 | $45.48 | $46.15 | $44.75 | $45.80 | 491.20K |
| Sep 22 | $45.37 | $46.55 | $45.22 | $46.17 | 441.80K |
| Sep 21 | $45.82 | $45.83 | $44.39 | $44.69 | 354.70K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →